Delayed presentation of late-onset cerebrospinal fluid rhinorrhoea following dopamine agonist therapy for giant prolactinoma

scientific article

Delayed presentation of late-onset cerebrospinal fluid rhinorrhoea following dopamine agonist therapy for giant prolactinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1530/EDM-14-0020
P932PMC publication ID4235146
P698PubMed publication ID25520847

P50authorBenjamin WhitelawQ83528817
P2093author name stringJ Gilbert
A King
N W Thomas
J K Prague
O G Mustafa
C L Ward
P2860cites workNonsurgical cerebrospinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological, and clinicopathological featuresQ36876662
Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patientsQ37981056
Spontaneous and medically induced cerebrospinal fluid leakage in the setting of pituitary adenomas: review of the literatureQ38015431
Giant prolactinomas: the therapeutic approach.Q38105620
Therapy of endocrine disease: the challenges in managing giant prolactinomasQ38188916
Pituitary prolactinomasQ40244609
Treatment of extensively invasive (giant) prolactinomas with bromocriptineQ41972064
Cerebrospinal fluid rhinorrhea occurring in long-term bromocriptine treatment for macroprolactinomasQ42199819
Advances in the management of CSF leaksQ42770289
Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).Q44314621
Giant prolactinomas in men: efficacy of cabergoline treatmentQ44406182
Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma: The Curse of the Secretory TumorQ44807120
The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomasQ48276339
Resistance to dopamine agonists in prolactinoma is correlated with reduction of dopamine D2 receptor long isoform mRNA levelsQ82733046
Low levels of PRB3 mRNA are associated with dopamine-agonist resistance and tumor recurrence in prolactinomasQ86547757
P921main subjectcerebrospinal fluidQ54196
prolactinomaQ954831
P304page(s)140020
P577publication date2014-11-01
P1433published inEndocrinology, diabetes & metabolism case reportsQ27725324
P1476titleDelayed presentation of late-onset cerebrospinal fluid rhinorrhoea following dopamine agonist therapy for giant prolactinoma
P478volume2014

Reverse relations

cites work (P2860)
Q54998565Endoscopic Trans-Sphenoidal surgery; Efficacy and response in Pituitary Adenoma.
Q89365542Just another case of bacterial meningitis… or… is it?
Q52588972Management of cystic prolactinomas: a review.
Q48967667Significance of surgical management for cystic prolactinoma
Q61446118Status epilepticus induced by treatment with dopamine agonist therapy for giant prolactinoma: a case report
Q36981276Successful treatment of a prolactinoma with the antipsychotic drug aripiprazole
Q44183655Ten-year follow-up of a giant prolactinoma

Search more.